当前位置: 首页 > 期刊 > 《中国现代医生》 > 2016年第27期
编号:12947849
MicroRNA—22—3p在食管鳞状细胞癌中的表达及临床意义(4)
http://www.100md.com 2016年9月25日 《中国现代医生》 2016年第27期
     [16] Baffa R,Fassan M,Volinia S,et al. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets[J]. J Pathol,2009,219(2):214-221.

    [17] Azbutyte V,Fiedler J,Kneitz S,et al. MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart[J]. Age(Dordr),2013,35(3):747-762.

    [18] Xiong J,Du Q,Liang Z. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein[J]. Oncogene,2010,29(35):4980-4988.

    [19] Nouraee N,Mowla SJ,Calin GA. Tracking miRNAs’ footprints in tumor-microenvironment interactions:Insights and implications for targeted cancer therapy[J]. Genes Chromosomes Cancer,2015,54(6):335-352.

    [20] Tsuchiya N,Izumiya M,Ogata-Kawata H,et al. Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21[J]. Cancer Res,2011,71(13):4628-4639.

    [21] Patel JB,Appaiah HN,Burnett RM,et al. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22[J]. Oncogene,2011,30(11):1290-1301.

    [22] Yamakuchi M,Yagi S,Ito T,et al. MicroRNA-22 regulates hypoxia signaling in colon cancer cells[J]. PLoS ONE,2011,6(5):e20291.

    (收稿日期:2016-04-27), 百拇医药(王江峰 陈晟 凌志强)
上一页1 2 3 4